Interleukin-10 from Marginal Zone Precursor B-Cell Subset Is Required for Costimulatory Blockade-Induced Transplantation Tolerance

Transplantation

Volumn 99, Issue 9, 2015, Pages 1817-1828

  Lal, Girdhari ^a,b   Nakayama, Yumi ^b   Sethi, Apoorva ^a   Singh, Amit K ^a   Burrell, Bryna E ^b   Kulkarni, Neeraja ^a   Brinkman, C Colin ^b   Iwami, Daiki ^b   Zhang, Tianshu ^b   Bromberg, Jonathan S ^b  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; CD19 ANTIGEN; CD1D ANTIGEN; CD5 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 21 RECEPTOR; KIDNEY INJURY MOLECULE 1; MEMBRANE PROTEIN; PROTEIN TIM4; UNCLASSIFIED DRUG; CD40 ANTIGEN; CD40 LIGAND; IL10 PROTEIN, MOUSE; IL21R PROTEIN, MOUSE; INTERLEUKIN 21 RECEPTOR ALPHA; MONOCLONAL ANTIBODY;

ACUTE GRAFT REJECTION; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIAC GRAFT REJECTION; CONTROLLED STUDY; COSTIMULATORY BLOCKADE; CYTOKINE PRODUCTION; FLOW CYTOMETRY; HEART TRANSPLANTATION; HUMORAL IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; MARGINAL ZONE PRECURSOR B CELL; MOUSE; NONHUMAN; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSPLANTATION TOLERANCE; WILD TYPE; ADVERSE EFFECTS; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL CULTURE; DEFICIENCY; GENETICS; GRAFT REJECTION; GRAFT SURVIVAL; HEART MUSCLE; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE DEPLETION; METABOLISM; PATHOLOGY; PHENOTYPE; SIGNAL TRANSDUCTION; TIME; TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD40; CD40 LIGAND; CELLS, CULTURED; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMANS; INTERLEUKIN-10; INTERLEUKIN-21 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE DEPLETION; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIUM; PHENOTYPE; PRECURSOR CELLS, B-LYMPHOID; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSPLANTATION TOLERANCE;

EID: 84938495594     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000718     Document Type: Article

References (50)

1. Pilat N, Sayegh MH, Wekerle T. Costimulatory pathways in transplantation. Semin Immunol. 2011;23:293-303.
2. Quezada SA, Jarvinen LZ, Lind EF, et al. CD40/CD154 interactions at the interface of tolerance and immunity. Annu Rev Immunol. 2004; 22:307-328.
3. Ochando JC, Homma C, Yang Y, et al. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat Immunol. 2006;7:652-662.
4. Kelishadi SS, Azimzadeh AM, Zhang T, et al. Preemptive CD20+ B cell depletion attenuates cardiac allograft vasculopathy in cyclosporinetreated monkeys. J Clin Invest. 2010;120:1275-1284.
5. DiLillo DJ, Griffiths R, Seshan SV, et al. B lymphocytes differentially influence acute and chronic allograft rejection in mice. J Immunol. 2011;186:2643-2654.
6. Sagoo P, Perucha E, Sawitzki B, et al. Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest. 2010;120:1848-1861.
7. Newell KA, Asare A, Kirk AD, et al. Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest. 2010;120:1836-1847.
8. Clatworthy MR, Watson CJ, Plotnek G, et al. B-cell-depleting induction therapy and acute cellular rejection. N Engl J Med. 2009; 360:2683-2685.
9. Liu C, Noorchashm H, Sutter JA, et al. B lymphocyte-directed immunotherapy promotes long-term islet allograft survival in nonhuman primates. Nat Med. 2007;13:1295-1298.
10. Bennett SR, Carbone FR, Toy T, et al. B cells directly tolerize CD8(+) T cells. J ExpMed. 1998;188:1977-1983.
11. Hollsberg P, Batra V, Dressel A, et al. Induction of anergy in CD8 Tcells by B cell presentation of antigen. J Immunol. 1996;157:5269-5276.
12. Reichardt P, Dornbach B, Rong S, et al. Naive B cells generate regulatory T cells in the presence of a mature immunologic synapse. Blood. 2007;110:1519-1529.
13. Mizoguchi E, Mizoguchi A, Preffer FI, et al. Regulatory role of mature B cells in a murine model of inflammatory bowel disease. Int Immunol. 2000;12:597-605.
14. Moulin V, Andris F, Thielemans K, et al. B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation. J Exp Med. 2000;192:475-482.
15. Rowley DA, Stach RM. B lymphocytes secreting IgG linked to latent transforming growth factor-beta prevent primary cytolytic T lymphocyte responses. Int Immunol. 1998;10:355-363.
16. Yanaba K, Bouaziz JD, Haas KM, et al. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity. 2008;28:639-650.
17. Matsushita T, Horikawa M, Iwata Y, et al. Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. J Immunol. 2010;185:2240-2252.
18. Blair PA, Norena LY, Flores-Borja F, et al. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus erythematosus patients. Immunity. 2010;32:129-140.
19. Candando KM, Lykken JM, Tedder TF. B10 cell regulation of health and disease. Immunol Rev. 2014;259:259-272.
20. Nagano H, Mitchell RN, Taylor MK, et al. Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. J Clin Invest. 1997;100:550-557.
21. Cooper JD, Billingham M, Egan T, et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 1993;12:713-716.
22. Shimizu K, Schonbeck U, Mach F, et al. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis. J Immunol. 2000;165:3506-3518.
23. Korn T, Mitsdoerffer M, Croxford AL, et al. IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells. Proc Natl Acad Sci USA. 2008;105: 18460-18465.
24. Yi H, Guo C, Yu X, et al. Mouse CD11b+Gr-1+ myeloid cells can promote Th17 cell differentiation and experimental autoimmune encephalomyelitis. J Immunol. 2012;189:4295-4304.
25. Asano K, Nabeyama A, Miyake Y, et al. CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens. Immunity. 2011;34:85-95.
26. Ding Q, Yeung M, Camirand G, et al. Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. J Clin Invest. 2011;121:3645-3656.
27. Good KL, Bryant VL, Tangye SG. Kinetics of human B cell behavior and amplification of proliferative responses following stimulation with IL-21. J Immunol. 2006;177:5236-5247.
28. Spolski R, Kim HP, Zhu W, et al. IL-21 mediates suppressive effects via its induction of IL-10. J Immunol. 2009;182:2859-2867.
29. Kirk AD, Turgeon NA, Iwakoshi NN. B cells and transplantation tolerance. Nat Rev Nephrol. 2010;6:584-593.
30. Gareau A, Hirsch GM, Lee TD, et al. Contribution of B cells and antibody to cardiac allograft vasculopathy. Transplantation. 2009;88:470-477.
31. Le Texier L, Thebault P, Lavault A, et al. Long-term allograft tolerance is characterized by the accumulation of B cells exhibiting an inhibited profile. Am J Transplant. 2011;11:429-438.
32. Chesneau M, Pallier A, Braza F, et al. Unique B cell differentiation profile in tolerant kidney transplant patients. Am J Transplant. 2014; 14:144-155.
33. Moritoki Y, Lian ZX, Lindor K, et al. B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative mice. Hepatology. 2009;50:1893-1903.
34. Hjelmstrom P, Juedes AE, Fjell J, et al. B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization. J Immunol. 1998;161: 4480-4483.
35. Dhirapong A, Lleo A, Yang GX, et al. B cell depletion therapy exacerbates murine primary biliary cirrhosis. Hepatology. 2011;53:527-535.
36. Teichmann LL, Kashgarian M, Weaver CT, et al. B cell-derived IL-10 does not regulate spontaneous systemic autoimmunity in MRL.Fas(lpr) mice. J Immunol. 2012;188:678-685.
37. Carter NA, Vasconcellos R, Rosser EC, et al.Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J Immunol. 2011;186:5569-5579.
38. Lee KM, Kim JI, Stott R, et al. Anti-CD45RB/anti-TIM-1-induced tolerance requires regulatory B cells. Am J Transplant. 2012;12:2072-2078.
39. Deng S, Moore DJ, Huang X, et al. Cutting edge: transplant tolerance induced by anti-CD45RB requires B lymphocytes. J Immunol. 2007; 178:6028-6032.
40. Zhao G, Moore DJ, Lee KM, et al. An unexpected counter-regulatory role of IL-10 in B-lymphocyte-mediated transplantation tolerance. Am J Transplant. 2010;10:796-801.
41. Li Y, Li XC, Zheng XX, et al. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat Med. 1999;5:1298-1302.
42. Monk NJ, Hargreaves RE, Marsh JE, et al. Fc-dependent depletion of activated T cells occurs through CD40L-specific antibody rather than costimulation blockade. Nat Med. 2003;9:1275-1280.
43. Nanji SA, Hancock WW, Luo B, et al. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse. Diabetes. 2006;55:27-33.
44. Yoshizaki A, Miyagaki T, DiLillo DJ, et al. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature. 2012;491:264-268.
45. Burrell BE, Ding Y, Nakayama Y, et al. Tolerance and lymphoid organ structure and function. Front Immunol. 2011;2:64.
46. Cerutti A, Cols M, Puga I. Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes. Nat Rev Immunol. 2013;13: 118-132.
47. Kanayama N, Cascalho M, Ohmori H. Analysis of marginal zone B cell development in the mouse with limited B cell diversity: role of the antigen receptor signals in the recruitment of B cells to the marginal zone. J Immunol. 2005;174:1438-1445.
48. Baumjohann D, Preite S, Reboldi A, et al. Persistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype. Immunity. 2013;38:596-605.
49. Linterman MA, PiersonW, Lee SK, et al. Foxp3+ follicular regulatory Tcells control the germinal center response. Nat Med. 2011;17:975-982.
50. Nakayama Y, Bromberg JS. Lymphotoxin-beta receptor blockade induces inflammation and fibrosis in tolerized cardiac allografts. Am J Transplant. 2012;12:2322-2334.